Patricia A. Bradford - 27 Apr 2022 Form 3 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
27 Apr 2022
Net transactions value
$0
Form type
3
Filing time
29 Apr 2022, 18:00:34 UTC
Next filing
26 Sep 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.